Isorhamnetin ameliorates dopaminergic neuronal damage via targeting FOSL1 to activate AKT/mTOR in 6-OHDA-induced SH-SY5Y cells
Journal of Neurophysiology · 2025
DOI: 10.1152/jn.00351.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurophysiology, 2025. Verfasst von Shaochen Qin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Hospital Affiliated to Shanxi University of Chinese Medicine, Taiyuan, People's Republic of China. Hauptthemen laut MEDLINE: Oxidopamine, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases, Quercetin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: national regional medical center of traditional Chinese medicine of Chin, Health Commission of Shanxi Province ().
Abstract (Originalsprache)
Isorhamnetin (Iso) ameliorated neuronal activity damage, senescence, apoptosis, and oxidative stress injury in 6-hydroxydopamine (6-OHDA)-induced SH-SY5Y cells. Iso activated AKT/mTOR signaling pathway via inhibiting Fos-like antigen (FOSL1) in 6-OHDA-induced SH-SY5Y cells. Overexpression of FOSL1 attenuated the protective effect of Iso against 6-OHDA-induced neuronal damage in SH-SY5Y cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The Hospital Affiliated to Shanxi University of Chinese Medicine, Taiyuan, People's Republic of China.
- Department of Acupuncture and moxibustion, The Hospital Affiliated to Shanxi University of Chinese Medicine, Taiyuan, People's Republic of China.
- Department of Neurosurgery, Xi'an International Medical Center Hospital, Xi'an, People's Republic of China.
ORCID-Profile: Mingsheng Chen
Förderung
- national regional medical center of traditional Chinese medicine of Chin
- Health Commission of Shanxi Province ()
Zitieren
APA
Qin, S., Wan, X., Kong, S., Xu, K., Jin, J., He, S., & Chen, M. (2025). Isorhamnetin ameliorates dopaminergic neuronal damage via targeting FOSL1 to activate AKT/mTOR in 6-OHDA-induced SH-SY5Y cells. Journal of Neurophysiology. https://doi.org/10.1152/jn.00351.2024
Vancouver
Qin S, Wan X, Kong S, Xu K, Jin J, He S, et al. Isorhamnetin ameliorates dopaminergic neuronal damage via targeting FOSL1 to activate AKT/mTOR in 6-OHDA-induced SH-SY5Y cells. Journal of Neurophysiology. 2025. doi:10.1152/jn.00351.2024
BibTeX
@article{Qin2025,
author = {Qin, Shaochen and Wan, Xiaobo and Kong, Shanshan and Xu, Kunmei and Jin, Jungong and He, Shiming and Chen, Mingsheng},
title = {Isorhamnetin ameliorates dopaminergic neuronal damage via targeting FOSL1 to activate AKT/mTOR in 6-OHDA-induced SH-SY5Y cells},
journal = {Journal of Neurophysiology},
year = {2025},
doi = {10.1152/jn.00351.2024}
}
EUVIMED